Therapeutic Asset Ratings
234 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Estrogen Receptor-positive Breast Cancer
Dana-Farber Cancer Institute
P3
BB
(64)
LEUPROLIDE
Acute Lymphoblastic Leukemia ALL
Dana-Farber Cancer Institute
P2
BB
(64)
Trastuzumab Emtansine
HER-2 Positive Breast Cancer
Dana-Farber Cancer Institute
P2/3
BB
(64)
Iberdomide
Multiple Myeloma
Dana-Farber Cancer Institute
P3
B
(63)
Cyclophosphamide
Smoldering Multiple Myeloma
Dana-Farber Cancer Institute
P2
B
(63)
Evomela
Myelogenous Leukemia
Dana-Farber Cancer Institute
P2
B
(63)
Epirubicin
Primary Central Nervous System Lymphoma
Dana-Farber Cancer Institute
P2
B
(62)
Inotuzumab Ozogamicin
Lymphoma, B-Cell
Dana-Farber Cancer Institute
P2
B
(62)
Pembrolizumab
Primary Central Nervous System Lymphoma
Dana-Farber Cancer Institute
P2
B
(62)
Decitabine
Leukemia
Dana-Farber Cancer Institute
P2/3
B
(62)
Everolimus
Skin Cancer
Dana-Farber Cancer Institute
P4
B
(61)
Montanide Isa 51
Melanoma (Skin)
Dana-Farber Cancer Institute
P3
B
(61)
Atezolizumab
Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute
P3
B
(60)
Everolimus
Cancer
Dana-Farber Cancer Institute
P3
B
(60)
Nelarabine
Acute Lymphoblastic Leukemia, Pediatric
Dana-Farber Cancer Institute
P3
B
(60)
Busulphan
Leukemia, Myeloid
Dana-Farber Cancer Institute
P2
B
(60)
Cyclophosphamide
Leukemia, B-Cell
Dana-Farber Cancer Institute
P2
B
(60)
Docetaxel
ER-positive Breast Cancer
Dana-Farber Cancer Institute
P2
B
(60)
Epirubicin
Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter
Dana-Farber Cancer Institute
P2
B
(60)
Hyaluronidase zzxf
Advanced Breast Carcinoma
Dana-Farber Cancer Institute
P2
B
(60)
Nivolumab
Adrenal Cortical Carcinoma
Dana-Farber Cancer Institute
P2
B
(60)
Pembrolizumab
Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter
Dana-Farber Cancer Institute
P2
B
(60)
Tucatinib
ER Positive Breast Cancer
Dana-Farber Cancer Institute
P2
B
(60)
Dexrazoxane
Acute Lymphoblastic Leukemia, Pediatric
Dana-Farber Cancer Institute
P3
B
(59)
Erwinia L-Asparaginase
Acute Lymphoblastic Leukemia, Pediatric
Dana-Farber Cancer Institute
P3
B
(59)
Showing 26 to 50 of 234 assets
Previous
Page 2 of 10
Next